(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.33%) $0.935
(0.55%) $11.01
(0.17%) $0.801
(0.00%) $92.17
Live Chart Being Loaded With Signals
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemical, ingredients, and additive blend products in India and internationally...
Stats | |
---|---|
Šios dienos apimtis | 355 630 |
Vidutinė apimtis | 1.02M |
Rinkos kapitalizacija | 18.19B |
EPS | INR0 ( 2024-02-09 ) |
Kita pelno data | ( INR0 ) 2024-05-20 |
Last Dividend | INR0.450 ( 2016-07-28 ) |
Next Dividend | INR0 ( N/A ) |
P/E | -472.17 |
ATR14 | INR0.134 (0.12%) |
Tūris Koreliacija
Camlin Fine Sciences Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
CENTUM.NS | 0.816 |
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Camlin Fine Sciences Koreliacija - Valiuta/Žaliavos
Camlin Fine Sciences Finansinės ataskaitos
Annual | 2022 |
Pajamos: | INR16.82B |
Bruto pelnas: | INR8.68B (51.64 %) |
EPS: | INR3.11 |
FY | 2022 |
Pajamos: | INR16.82B |
Bruto pelnas: | INR8.68B (51.64 %) |
EPS: | INR3.11 |
FY | 2022 |
Pajamos: | INR14.09B |
Bruto pelnas: | INR6.40B (45.43 %) |
EPS: | INR4.65 |
FY | 2021 |
Pajamos: | INR11.81B |
Bruto pelnas: | INR5.86B (49.64 %) |
EPS: | INR4.13 |
Financial Reports:
No articles found.
Camlin Fine Sciences Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
First Dividend | INR0.450 | 2015-07-27 |
Last Dividend | INR0.450 | 2016-07-28 |
Next Dividend | INR0 | N/A |
Payout Date | 2016-09-10 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | INR0.900 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.84 | -- |
Div. Sustainability Score | 0.424 | |
Div.Growth Potential Score | 1.741 | |
Div. Directional Score | 1.082 | -- |
Year | Amount | Yield |
---|---|---|
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR0 | 0.00% |
2019 | INR0 | 0.00% |
2020 | INR0 | 0.00% |
2021 | INR0 | 0.00% |
2022 | INR0 | 0.00% |
2023 | INR0 | 0.00% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SILINV.NS | Dividend Junior | 2023-08-18 | Annually | 23 | 0.63% | |
MBAPL.NS | Dividend Junior | 2023-09-18 | Annually | 8 | 0.44% | |
GUJAPOLLO.NS | Ex Dividend Junior | 2023-09-22 | Annually | 18 | 0.48% | |
BAYERCROP.NS | Dividend Junior | 2023-08-03 | Annually | 15 | 1.25% | |
PREMIERPOL.NS | Dividend Junior | 2023-09-11 | Sporadic | 9 | 0.39% | |
KAMDHENU.NS | Dividend Junior | 2023-08-14 | Sporadic | 17 | 0.32% | |
EDELWEISS.NS | Dividend Junior | 2023-09-18 | Annually | 17 | 2.38% | |
ADSL.NS | Dividend Junior | 2023-08-10 | Sporadic | 16 | 0.91% | |
STERTOOLS.NS | Dividend Junior | 2023-09-11 | Annually | 19 | 0.38% | |
NAHARCAP.NS | No Dividend Player | 2023-09-08 | Annually | 17 | 0.70% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.00394 | 1.500 | -0.0788 | -0.118 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | -0.00732 | 1.500 | -1.192 | -1.789 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 1.418 | 1.000 | -0.586 | -0.586 | [3 - 30] |
operatingCashFlowPerShareTTM | 7.14 | 2.00 | 7.62 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 7.14 | 2.00 | 6.43 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.473 | 1.000 | 5.45 | 5.45 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0248 | 1.000 | -1.504 | -1.504 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 0.424 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -281.79 | 1.000 | -10.00 | 0 | [1 - 100] |
returnOnEquityTTM | -0.00732 | 2.50 | -0.767 | -1.789 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 7.14 | 2.00 | 7.62 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 7.14 | 2.00 | 7.62 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 8.51 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0729 | 1.000 | -0.677 | 0 | [0.1 - 0.5] |
Total Score | 1.741 |
Camlin Fine Sciences
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemical, ingredients, and additive blend products in India and internationally. It offers shelf-life solutions, which include antioxidants comprises Tertiary Butyl Hydroquinone, Butylated Hydroxy Anisole, and Ascorbyl palmitate; and mold inhibitors, preservatives, acidifiers, antibacterial agents, toxin binders, pellet binders, and growth promoters, as well as natural antioxidants, such as mixed tocopherols, green tea extract, rosemary extract, and acerola extract that are used to enhance the shelf life under the Xtendra and NaSure brands. The company also provides aroma ingredients, including vanillin and ethyl vanillin; and nutraceutical products from fermentation and plant extraction sources. In addition, it offers performance chemicals, such as hydroquinone and catechol; and downstream fine chemicals, including Guaiacol, Veratrole, TBC, MEHQ, HQEE, etc. The company also exports its products. Its products are used in food and beverage, pet food and animal nutrition, biodiesel, aquaculture, rendering, petrochemical, agrochemical, pharmaceutical, polymers, dyes and pigment, biscuits and cookies, chocolate and confectionery, fragrance manufacturing, bakery, flavor, electroplating, and dietary supplement industries. The company was formerly known as Camlin Fine Chemicals Limited and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.